IP Library › Granted Patent US 8,993,586
Granted Patent B2
US 8,993,586 · App. 14/497,396 · Granted Mar 31, 2015

N1/N2-lactam acetyl-CoA carboxylase inhibitors

Inventors: David A. Griffith (Sudbury, MA); Robert L. Dow (Groton, CT); Scott W. Bagley (Mystic, CT); Aaron Smith (North Providence, RI)
Assignee: Pfizer Inc.
C07D471/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,993,586
App. No.
14/497,396
Granted
Mar 31, 2015
Kind
B2
Abstract

The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R 1 , R 2 and R 3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.

Claims (4)

1. A compound of structure

or a pharmaceutically acceptable salt thereof.

2. A compound of structure

3. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient, diluent, or carrier.

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →
Continuity (4)
Continuation 13282964 · Oct 27, 2011
Provisional Application 61531744 · Sep 7, 2011
Provisional Application 61408127 · Oct 29, 2010
Related Publication 20150025098A1 · Jan 22, 2015